We successfully represented a public company in an 18-month Securities & Exchange Commission (SEC) investigation related to accounting and disclosure issues, resulting in a decision by the SEC to terminate the investigation and recommend that no enforcement action be taken. In defending the company, we responded to requests for documents and information, presented to the SEC and represented company officials at in-person meetings with the SEC.
Successful Defense of SEC Investigation into Accounting and Disclosure Issues
Client Type: Public Company
You Also May Be Interested In:
Representation of Mallinckrodt Pharmaceuticals, a global pharmaceutical manufacturer, in numerous cases in courts across Tennessee, Kentucky, and Virginia